Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist.
about
Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responsesNewcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell deathViral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-AntagonistsThe C proteins of human parainfluenza virus type 1 block IFN signaling by binding and retaining Stat1 in perinuclear aggregates at the late endosomeComparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vectorAntagonist peptides of human interferon-alpha2b isolated from phage display library inhibit interferon induced antiviral activity.New World hantaviruses activate IFNlambda production in type I IFN-deficient vero E6 cells.The cytoplasmic location of chicken mx is not the determining factor for its lack of antiviral activityMumps virus V protein antagonizes interferon without the complete degradation of STAT1.Identification of paramyxovirus V protein residues essential for STAT protein degradation and promotion of virus replication.Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy.Human parainfluenza virus type 4 is incapable of evading the interferon-induced antiviral effectDetecting remote sequence homology in disordered proteins: discovery of conserved motifs in the N-termini of Mononegavirales phosphoproteinsInduction of type I interferon secretion through recombinant Newcastle disease virus expressing measles virus hemagglutinin stimulates antibody secretion in the presence of maternal antibodiesGeneration by reverse genetics of an effective, stable, live-attenuated newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strainMorbillivirus v proteins exhibit multiple mechanisms to block type 1 and type 2 interferon signalling pathwaysDifferentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines.Mutations in the fusion protein cleavage site of avian paramyxovirus serotype 2 increase cleavability and syncytium formation but do not increase viral virulence in chickens.Rinderpest virus blocks type I and type II interferon action: role of structural and nonstructural proteins.New avian paramyxoviruses type I strains identified in Africa provide new outcomes for phylogeny reconstruction and genotype classification.Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens.Characterization of the amino acid residues of sendai virus C protein that are critically involved in its interferon antagonism and RNA synthesis down-regulation.Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and catsAntagonism of innate immunity by paramyxovirus accessory proteins.Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigsImportance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice.Genomic and biological characterization of a velogenic Newcastle disease virus isolated from a healthy backyard poultry flock in 2010Mutation of the f-protein cleavage site of avian paramyxovirus type 7 results in furin cleavage, fusion promotion, and increased replication in vitro but not increased replication, tissue tropism, or virulence in chickens.Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus.Newcastle Disease Virus V Protein Targets Phosphorylated STAT1 to Block IFN-I Signaling.Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1.Host Innate Immune Responses of Ducks Infected with Newcastle Disease Viruses of Different PathogenicitiesStrong innate immune response and cell death in chicken splenocytes infected with genotype VIId Newcastle disease virus.Newcastle disease virus infection in chicken embryonic fibroblasts but not duck embryonic fibroblasts is associated with elevated host innate immune response.Human parainfluenza virus type 2 V protein inhibits genome replication by binding to the L protein: possible role in promoting viral fitness.The large polymerase protein is associated with the virulence of Newcastle disease virus.Studies on the paramyxovirus accessory genes by reverse genetics in the Sendai virus-mouse system.Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy.Interferon regulatory factor 3 is a key regulation factor for inducing the expression of SAMHD1 in antiviral innate immunity.The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence.
P2860
Q24631361-FFA7F674-6A9C-4288-B5D3-374925C32BBBQ24674186-0B726956-BDC4-4DC8-B441-CCE85DB338C4Q26745547-8D7CE34B-A496-4F1F-9820-D139C7F881FBQ27311445-35907737-F5DF-48FB-ACE2-478BECDA14DEQ28533970-F155BDC8-0CD8-4F6E-BCE3-1BDB6E87032AQ33251738-FE1662B5-DCB4-4EF3-9D19-2ECA8816A4FFQ33612256-7C89B3C0-C997-448D-B337-A2CE039AC1A8Q33679910-BD943F83-1825-4A4C-9D1F-C179629D7E71Q33707477-FF4111C6-146D-45FD-92B5-1940240212D7Q33843478-733A66DF-6E0A-40F4-971E-24A2A3D224DAQ34028464-69D3B5AF-3EB7-4E99-9F90-A7A86DB7A2A4Q34142854-41E12E09-D98C-4608-9E75-A2E1123FAE96Q34189305-C17F8054-A9C6-4038-9696-B2ABD5B0157EQ34457996-30FED2E3-A36A-4748-A971-D9CD9A39295BQ34534541-C8942019-61CF-4544-B95B-437B614A50D2Q34595223-7C8741D8-6F7C-4298-97F7-FC4C7A7FE7FFQ34648125-A1BBD249-212F-46A6-9E52-7778025902B4Q34982625-13362EF7-D77E-46A3-8404-5D5895AE3218Q35023714-58CD1C97-E9E4-4D79-B3FE-70F3EF4AE687Q35034669-F7A59A0E-FC58-4A8A-9C08-C5A292268D94Q35077454-5F112B5E-5B07-4722-8842-957A705C6D2AQ35122376-5DFDC7A5-5463-42A4-8636-FCC7EFDFE731Q35140435-8DD20B3B-68EA-4E2B-9E10-00817488E98FQ35259962-7C6CA673-6FFB-4003-8EDF-48A18D984F52Q35275117-79847B80-0BEA-4750-B66D-A8FB94DFB8B3Q35785013-9E9C2AB5-0A1E-48E7-AC58-730642CDDBBCQ35809039-8667F50D-CB82-4B55-B68B-343611844DB5Q35826852-F8167700-1AF4-4FEF-8049-9277EB9DC9C3Q35886963-BA88CA4F-BABA-4C62-968B-3A8695E6213DQ35918371-24AAB184-FD9D-44C4-B80F-021AAA6C3559Q36190495-4A07F1A9-C1C2-4EBE-8231-57A3E1793199Q36285183-6D2F18CA-59B2-4288-88C0-3E1570DEF89BQ36373481-478CB8D0-4ABC-4047-93F8-DAA9246EA471Q36687235-8E4FB1E0-3B79-4EDB-BDC0-DCCDBF9BBA2AQ36747923-A862B007-969A-4984-B481-DCBAFB055121Q36845605-62BAF344-D670-4C2A-9055-553B547E223EQ37038283-ABB3D931-DAFA-437C-87FE-A758FEEC28F9Q37069810-5A536CAE-E023-48A3-B5EB-89AFC8D6C440Q37093160-B60A0B51-D518-40BE-8C60-6386C48106AAQ37094277-8A58A8A4-53B5-4C6A-A42E-7FB7CE8258D4
P2860
Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Newcastle disease virus V prot ...... n alpha interferon antagonist.
@en
Newcastle disease virus V prot ...... n alpha interferon antagonist.
@nl
type
label
Newcastle disease virus V prot ...... n alpha interferon antagonist.
@en
Newcastle disease virus V prot ...... n alpha interferon antagonist.
@nl
prefLabel
Newcastle disease virus V prot ...... n alpha interferon antagonist.
@en
Newcastle disease virus V prot ...... n alpha interferon antagonist.
@nl
P2093
P2860
P1433
P1476
Newcastle disease virus V prot ...... n alpha interferon antagonist.
@en
P2093
Aruna Panda
Sateesh Krishnamurthy
Siba K Samal
Zhuhui Huang
P2860
P304
P356
10.1128/JVI.77.16.8676-8685.2003
P407
P577
2003-08-01T00:00:00Z